These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The evolving role of antiepileptic drugs in treating neuropathic pain. Ross EL Neurology; 2000; 55(5 Suppl 1):S41-6; discussion S54-8. PubMed ID: 11001361 [TBL] [Abstract][Full Text] [Related]
4. Treatment of pain with antidepressants. Clifford DB Am Fam Physician; 1985 Feb; 31(2):181-5. PubMed ID: 2983520 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? Perahia DG; Pritchett YL; Desaiah D; Raskin J Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978 [TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Bomholt SF; Mikkelsen JD; Blackburn-Munro G Neuropharmacology; 2005 Feb; 48(2):252-63. PubMed ID: 15695164 [TBL] [Abstract][Full Text] [Related]
8. Management of neuropathic pain. Jensen TS; Finnerup NB Curr Opin Support Palliat Care; 2007 Aug; 1(2):126-31. PubMed ID: 18685353 [TBL] [Abstract][Full Text] [Related]
9. Medications for neuropathic pain: current trends. Colombo B; Annovazzi PO; Comi G Neurol Sci; 2006 May; 27 Suppl 2():S183-9. PubMed ID: 16688627 [TBL] [Abstract][Full Text] [Related]
10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
11. Pregabalin: new drug. Very similar to gabapentin. Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience with dual action antidepressants in different chronic pain syndromes. Briley M Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S21-5. PubMed ID: 15378667 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of duloxetine in fibromyalgia. Ursini F; Pipicelli G; Grembiale RD Clin Ter; 2010; 161(4):391-5. PubMed ID: 20931165 [TBL] [Abstract][Full Text] [Related]
14. Advances in the management of neuropathic pain. Carter GT; Galer BS Phys Med Rehabil Clin N Am; 2001 May; 12(2):447-59. PubMed ID: 11345017 [TBL] [Abstract][Full Text] [Related]
15. A new look at the second-generation antiepileptic drugs: a decade of experience. LaRoche SM Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological treatment of neuropathic pain]. Ollat H Rev Neurol (Paris); 1992; 148(8-9):521-31. PubMed ID: 1337388 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoids for the treatment of neuropathic pain: clinical evidence. Ashton JC; Milligan ED Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533 [TBL] [Abstract][Full Text] [Related]
18. Antidepressant and anticonvulsant medication for chronic pain. Sullivan MD; Robinson JP Phys Med Rehabil Clin N Am; 2006 May; 17(2):381-400, vi-vii. PubMed ID: 16616273 [TBL] [Abstract][Full Text] [Related]
19. [Neuropathic pains: background, new tools, new drugs]. Kuntzer T; Decosterd I Rev Med Suisse; 2005 Nov; 1(43):2812-6. PubMed ID: 16396371 [TBL] [Abstract][Full Text] [Related]
20. Fibromyalgia syndrome: an overview of potential drug targets. Briley M; Moret C IDrugs; 2003 Jul; 6(7):668-73. PubMed ID: 12861471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]